Related Experiment Video
Updated: Jun 13, 2026

Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation
Published on: August 21, 2017
STING dampens the unfolded protein response to enable the presentation of self-antigens on MHC-I during inflammation
Ahmed M Fahmy1, Ali Ahmadi1, Joël Lanoix2
1Département de Pathologie et Biologie Cellulaire, Université de Montréal, Montréal, QC H3T 1J4, Canada; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD 20815, USA.
Abstract:
A growing body of evidence supports the contribution of the long-lasting adaptive immune system in Parkinson's disease (PD). We showed that the PD-associated protein PINK1 negatively regulates the presentation of mitochondrial antigens (MitAP) on MHC-I molecules. In vivo evidence indicated that MitAP activation in mice, in the absence of PINK1, led to cytotoxic CD8+ T cell stimulation and severe motor impairments, reversible by L-DOPA. We show here that following TLR4 activation, MitAP is engaged through a pathway involving cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING), which acts as a rheostat to dampen the unfolded protein response (UPR). Without STING, the stress response is amplified, leading to a translational attenuation that inhibits the expression of XBP1s, a transcription factor required for MitAP. STING activity also regulates the repertoire of peptides displayed at the cell surface during inflammation, highlighting a potential role in immunosurveillance. These findings establish STING and the UPR as key immune regulators targetable for therapeutic intervention during autoimmune diseases and PD.
Insights
Parkinson's disease involves the adaptive immune system. STING and the unfolded protein response (UPR) regulate mitochondrial antigen presentation, offering new therapeutic targets for PD and autoimmune diseases.
Area of Science:
- Neuroimmunology
- Molecular Biology
- Immunology
Background:
- Adaptive immunity plays a role in Parkinson's disease (PD).
- The protein PINK1 influences mitochondrial antigen presentation (MitAP) on MHC-I molecules.
- MitAP activation in PINK1-deficient mice causes motor deficits.
Purpose of the Study:
- To investigate the role of STING and UPR in MitAP regulation.
- To explore the therapeutic potential of targeting STING and UPR in PD.
Main Methods:
- Studied the cGAS-STING pathway in response to TLR4 activation.
- Assessed the impact of STING on UPR and XBP1s expression.
- Analyzed peptide presentation on cell surfaces during inflammation.
Main Results:
- TLR4 activation engages cGAS-STING pathway, dampening UPR.
- STING deficiency amplifies stress response, inhibiting XBP1s and MitAP.
- STING regulates peptide repertoire, suggesting a role in immunosurveillance.
Conclusions:
- STING and UPR are critical regulators of MitAP.
- STING and UPR represent potential therapeutic targets for PD and autoimmune diseases.
Related Concept Videos
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Regulation of the Unfolded Protein Response
The Unfolded Protein Response
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation

